Found: 11
Select item for more details and to access through your institution.
Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079573
- By:
- Publication type:
- Article
Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2437, doi. 10.3390/cancers15092437
- By:
- Publication type:
- Article
Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5195, doi. 10.3390/cancers14215195
- By:
- Publication type:
- Article
Establishment of Prostate Tumor Growth and Metastasis Is Supported by Bone Marrow Cells and Is Mediated by PIP5K1α Lipid Kinase.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2719, doi. 10.3390/cancers12092719
- By:
- Publication type:
- Article
FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 13, p. 2496, doi. 10.1002/1878-0261.13166
- By:
- Publication type:
- Article
Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 4, p. 846, doi. 10.1002/1878-0261.13158
- By:
- Publication type:
- Article
Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration‐resistant prostate cancer.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 4, p. 968, doi. 10.1002/1878-0261.12873
- By:
- Publication type:
- Article
The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 6, p. 1686, doi. 10.1002/ijc.32607
- By:
- Publication type:
- Article
Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer.
- Published in:
- Drug Design, Development & Therapy, 2013, v. 7, p. 875, doi. 10.2147/DDDT.S45703
- By:
- Publication type:
- Article
The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
- Published in:
- Molecular Medicine, 2018, v. 24, n. 1, p. N.PAG, doi. 10.1186/s10020-018-0035-4
- By:
- Publication type:
- Article
Correction: Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice